Description
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) comprising the full 44-amino-acid sequence of human GHRH with a trans-3-hexenoic acid modification at the N-terminus. It is supplied by Performance Clinics Research Sciences for qualified laboratory research use only.
Tesamorelin has been studied in peer-reviewed pre-clinical and clinical research for its GHRH receptor agonist activity and downstream effects on growth hormone and IGF-1 axis regulation in research models. Studies have characterised its N-terminal modification for improved proteolytic stability and its pharmacokinetic profile under controlled research conditions.
Product Specifications:
• Purity: ≥98% (HPLC verified)
• Appearance: White lyophilised powder
• Molecular Formula: C221H366N72O67S
• Molecular Weight: 5135.8 Da
• Storage: 2–8°C, protected from light and moisture
For research purposes only. Not for human or animal use or consumption.
